# ImmunityBio, Inc. Common Stock (IBRX)

ImmunityBio's Anktiva shows promising results in clinical trials, with potential EU approval and significant institutional buying, while facing scrutiny over financial performance and market manipulation concerns.

### About ImmunityBio, Inc. Common Stock
ImmunityBio, Inc. is a biotechnology company focused on developing treatments for cancer and infectious diseases.  
ImmunityBio, Inc. Common Stock uses the ticker $IBRX for trading. Listed in the [Stocks](/list/stocks) category.

### Insights
- ImmunityBio, Inc. Common Stock (IBRX) mentions hit [----] which is 361% higher than it's daily average.
- ImmunityBio, Inc. Common Stock (IBRX) creators hit [---] which is 267% higher than it's daily average.
- ImmunityBio, Inc. Common Stock (IBRX) social dominance hit [------] which is 254% higher than it's daily average.
- ImmunityBio, Inc. Common Stock (IBRX) trading volume is up 567.09% from the previous month.
- ImmunityBio, Inc. Common Stock (IBRX) social dominance is up 208.74% from the previous week.
- ImmunityBio, Inc. Common Stock (IBRX) Galaxy Score™ is up 14.29% from the previous week.
- ImmunityBio, Inc. Common Stock (IBRX) posts created is up 509.1% from the previous month.

### Price: $5.90
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$ibrx/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$ibrx/time-series/close.tsv)  
The stock price is experiencing upward momentum driven by strong revenue growth, positive clinical trial results, and significant short interest, suggesting a potential short squeeze, further supported by high trading volume and positive social sentiment.  

24-Hour: -7.85%
7-Day: -1.9%
30-Day: 7.7%

1-Year High: $7.30 on 2026-01-22  
1-Year Low: $1.90 on 2025-05-07  
  
  
### AltRank: [--]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$ibrx/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$ibrx/time-series/alt_rank.tsv)  
ImmunityBio, Inc. Common Stock (IBRX) is currently AltRank #62 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [---] +71  
[--] Month: [--] [----]  
[--] Months: [--] [----]  
[--] Year: [--] [----]  
1-Year High: [-----] on 2025-06-29  
1-Year Low: [--] on 2026-01-18  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$ibrx/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$ibrx/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +7  
[--] Month: [--] +1  
[--] Months: [--] +2  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-08-13  
1-Year Low: [--] on 2025-06-24  
  
  
### Engagements: [-------] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$ibrx/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$ibrx/time-series/interactions.tsv)  
Current Value: [-------]  
Daily Average: [------]  
[--] Week: [---------] -21%  
[--] Month: [----------] +996%  
[--] Months: [----------] +441%  
[--] Year: [----------] +184%  
1-Year High: [---------] on 2026-01-23  
1-Year Low: [-----] on 2025-05-10  

Engagements by network (24h):
YouTube: [-----]
News: [---]
Reddit: [---]
TikTok: [---]
X: [-------]

  
  
### Mentions: [-----] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$ibrx/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$ibrx/time-series/posts_active.tsv)  
Current Value: [-----]  
Daily Average: [---]  
[--] Week: [-----] +9.80%  
[--] Month: [------] +686%  
[--] Months: [------] +247%  
[--] Year: [------] +137%  
1-Year High: [-----] on 2026-01-21  
1-Year Low: [--] on 2025-08-09  

Mentions by network (24h):
YouTube: [--]
News: [--]
Reddit: [--]
TikTok: [--]
X: [-----]

  
  
### Creators: [---] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$ibrx/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$ibrx/time-series/contributors_active.tsv)  
[---] unique social accounts have posts mentioning ImmunityBio, Inc. Common Stock (IBRX) in the last [--] hours which is up 6.70% from [---] in the previous [--] hours
Daily Average: [---]  
[--] Week: [---] -1.80%  
[--] Month: [-----] +344%  
[--] Months: [-----] +106%  
[--] Year: [-----] +173%  
1-Year High: [-----] on 2026-01-21  
1-Year Low: [--] on 2025-05-03  

The most influential creators that mention ImmunityBio, Inc. Common Stock in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@Umbisam](/creator/twitter/Umbisam)                 | [--]    | [------]    | [--]    | [-----]       |
| [@ImmunityBio](/creator/twitter/ImmunityBio)         | [--]    | [------]    | [--]    | [-----]       |
| [@Alhmd120690](/creator/twitter/Alhmd120690)         | [--]    | [---]       | [--]    | [-----]       |
| [@boring_invest](/creator/twitter/boring_invest)     | [--]    | [---]       | [--]    | [-----]       |
| [@adamfeuerstein](/creator/twitter/adamfeuerstein)   | [--]    | [-------]   | [--]     | [-----]       |
| [@bullishbruk](/creator/twitter/bullishbruk)         | [--]    | [-----]     | [--]    | [-----]       |
| [@IdenixH](/creator/twitter/IdenixH)                 | [--]    | [---]       | [--]    | [-----]       |
| [@SaiseiInvesting](/creator/twitter/SaiseiInvesting) | [--]    | [-----]     | [--]    | [-----]       |
| [@SJCapitalInvest](/creator/twitter/SJCapitalInvest) | [--]    | [------]    | [--]     | [-----]       |
| [@petitnong_](/creator/twitter/petitnong_)           | [--]   | [-----]     | [--]    | [-----]       |

[View More](/list/creators/$ibrx/100)
  
  
### Sentiment: 77%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$ibrx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$ibrx/time-series/sentiment.tsv)  
Current Value: 77%  
Daily Average: 74%  
[--] Week: 74% -13%  
[--] Month: 75% -12%  
[--] Months: 75% +4%  
[--] Year: 75% +10%  
1-Year High: 98% on 2025-02-17  
1-Year Low: 12% on 2025-09-28  

Most Supportive Themes:
- Positive Sentiment and Recommendations: (45%) Posts highlight positive sentiment, stock recommendations, and potential for gains.
- Short Squeeze Potential: (25%) Mentions of high short interest and potential for a short squeeze.
- Positive News and Catalysts: (15%) Discussion of positive news, such as the potential of Anktiva and upcoming catalysts.
  
Most Critical Themes:
- Market Manipulation Concerns: (10%) Posts express concerns about market manipulation and the stock's price movement.
- Financial Performance Concerns: (5%) Mentions of the company's financial performance, including the widened net loss.
  
  
  
### Social Dominance: 0.082%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$ibrx/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$ibrx/time-series/social_dominance.tsv)  
Current Value: 0.082%  
Daily Average: 0.035%  
[--] Week: 0.138% +0.093%  
[--] Month: 0.124% -0.019%  
[--] Months: 0.124% +0.108%  
[--] Year: 0.124% +0.093%  
1-Year High: 0.357% on 2026-01-21  
1-Year Low: 0.0059% on 2025-08-09  
  
  
### Market Dominance: 0.00676%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$ibrx/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$ibrx/time-series/market_dominance.tsv)  
Current Value: 0.00676%  
Daily Average: 0%  
1-Year High: 0.096% on 2025-03-31  
1-Year Low: 0.00231% on 2025-12-30  
  
  
### Market Cap: $5,968,888,985
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$ibrx/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$ibrx/time-series/market_cap.tsv)  
Current Value: $5,968,888,985  
Daily Average: $2,665,195,050  
[--] Week: $6,008,287,592 +0.66%  
[--] Month: $5,968,888,985 +53%  
[--] Months: $5,968,888,985 +160%  
[--] Year: $5,968,888,985 +126%  
1-Year High: $7,229,644,414 on 2026-01-22  
1-Year Low: $1,668,152,573 on 2025-05-07  

### Top ImmunityBio, Inc. Common Stock News
Top news links shared on social in the last [--] hours  

*Showing a maximum of [--] news posts without a LunarCrush subscription.*  

"Top [--] Most Shorted Stocks: CleanSpark Hims & Hers And More - Cleanspark (NASDAQ:CLSK) Hims & Hers Health (NYSE:HIMS) ImmunityBio (NASDAQ:IBRX) Lucid Group (NASDAQ:LCID) - Benzinga Here's a look at the top ten. most shorted stocks in the market including Lucid Hims & Hers and CleanSpark"  
[News Link](https://www.benzinga.com/trading-ideas/movers/26/02/50625620/top-10-most-shorted-stocks-cleanspark-hims-hers-and-more) [@Benzinga](/creator/x/Benzinga) 2026-02-13T20:42Z 323K followers, [---] engagements



### Top ImmunityBio, Inc. Common Stock Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"$IBRX State Street Corp ImmunityBio Third Largest Institutional Holder Increases Its Stake By 5.1mil Shares In 4Q25 ie +45.4% Reaching Up 16.5mil Shares Overall. $IBRX Blackrock ImmunityBio Second Largest Institutional Holder Increases Its Stake By 5.8mil Shares In 4Q25 ie +29% Reaching Up 25.6mil Shares Overall. https://t.co/cLFTH7p6J3 $IBRX Blackrock ImmunityBio Second Largest Institutional Holder Increases Its Stake By 5.8mil Shares In 4Q25 ie +29% Reaching Up 25.6mil Shares Overall. https://t.co/cLFTH7p6J3"  
[X Link](https://x.com/Umbisam/status/2022692456039588135) [@Umbisam](/creator/x/Umbisam) 2026-02-14T15:20Z 18.1K followers, [----] engagements


"In every "top picks for 2026" I never saw $IBRX anywhere. I suspect that many stocks on those lists have more room for disappointment than for a positive surprise. Everyone went into [----] expecting the same and so they were already positioned. $IREN last year came seemingly out of the blue for the market. A few people saw the light earlier and discussed it between themselves. $IBRX feels similar although with all the variables that comes with being a biotech stock"  
[X Link](https://x.com/boring_invest/status/2022602034373927253) [@boring_invest](/creator/x/boring_invest) 2026-02-14T09:21Z [---] followers, [----] engagements


"Amanda I am sorry to hear Braelyn was denied access to the Anktiva trial [--] glioblastoma. Glad you'll pursue single-patient expanded access. It's become unconscionable that FDA hasn't approved Anktiva [--] glioblastoma & other cancers. Today we learned that Braelyn was denied access to the Anktiva clinical trial. Trial criteria are rigid. Cancer is not. We will now pursue single patient expanded access. We are not stopping. #GBM #Anktiva #ImmunityBio #ChildhoodCancer #SaveBraelyn https://t.co/I9yT1rCwLL Today we learned that Braelyn was denied access to the Anktiva clinical trial. Trial criteria"  
[X Link](https://x.com/CFSCentral/status/2022579325191799292) [@CFSCentral](/creator/x/CFSCentral) 2026-02-14T07:51Z [----] followers, [---] engagements


"This makes me so sad and so frustrated. @SecKennedy This girl deserves a chance. President Trump signed right to try and the @DrPatrick cannot take 15k applicants. Please give cancer patients hope. Braelyn is [--] years old. Please approve her for #ANKTIVA @bullishbruk Today we learned that Braelyn was denied access to the Anktiva clinical trial. Trial criteria are rigid. Cancer is not. We will now pursue single patient expanded access. We are not stopping. #GBM #Anktiva #ImmunityBio #ChildhoodCancer #SaveBraelyn https://t.co/I9yT1rCwLL Today we learned that Braelyn was denied access to the"  
[X Link](https://x.com/LoriMills4CA42/status/2022553789878931555) [@LoriMills4CA42](/creator/x/LoriMills4CA42) 2026-02-14T06:09Z 51.7K followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing